Breaking News Instant updates and real-time market news.

ALV

Autoliv

$104.08

-0.57 (-0.54%)

, VNE

Veoneer

$50.81

-1.81 (-3.44%)

11:12
07/21/18
07/21
11:12
07/21/18
11:12

Automotive spinoffs offer exposure to autonomous, electric future, Barron's says

Last month, Autoliv (ALV) completed a spinoff of Veoneer (VNE), which will make active safety systems that use lasers, cameras, and artificial intelligence to prevent accidents, Jack Hough writes in this week's edition of Barron's. In December, Delphi Automotive did the reverse, spinning off its out-of-fashion engine components into Delphi Technologies (DLPH), while keeping advanced electronics and active safety operations, and changing its name to Aptiv (APTV), he notes. These automotive spinoffs give investors new ways to buy targeted exposure to the autonomous, all-electric future of driving, but returns could be higher for companies serving the gas-guzzling present, the report adds. Reference Link

ALV

Autoliv

$104.08

-0.57 (-0.54%)

VNE

Veoneer

$50.81

-1.81 (-3.44%)

DLPH

Delphi Technologies

$44.78

-0.355 (-0.79%)

APTV

Aptiv

$92.95

-2.02 (-2.13%)

  • 31

    Jul

  • 08

    Aug

ALV Autoliv
$104.08

-0.57 (-0.54%)

07/18/18
07/18/18
DOWNGRADE
Target $115

Market Perform
Autoliv downgraded to Market Perform ahead of quarterly results at Wells Fargo
As previously reported, Wells Fargo analyst Richard Kwas downgraded Autoliv to Market Perform from Outperform ahead of quarterly results as he sees limited upside potential at the current time. The analyst notes that the company has quantified various financial targets through 2020, but while they seem achievable, his conviction in outperformance is limited. Kwas also lowered his price target on the shares to $115 from $176.
07/18/18
SOCG
07/18/18
INITIATION
Target $140
SOCG
Sell
Autoliv reinstated with a Sell at Societe Generale
Societe Generale reinstated Autoliv with a Sell and $140 price target.
07/18/18
07/18/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Neutral from Outperform at Macquarie with analyst Benjamin Schachter citing concerns about MAU trends, what he views as a limited set of near-term catalysts and a valuation he believes will likely limit upside from current levels. 2. Clorox (CLX) downgraded to Sell from Neutral at Goldman Sachs with analyst Jason English citing a combination of a lower volume forecast, lower gross margin expectation and renewed currency headwinds. 3. Autoliv (ALV) and Visteon (VC) were downgraded to Market Perform from Outperform at Wells Fargo. 4. Broadcom (AVGO) downgraded to Neutral from Buy at Goldman Sachs with analyst Toshiya Hari saying he sees increased uncertainty surrounding the company's "strategic focus going forward" following its acquisition of CA Technologies (CA). 5. Windstream (WIN) and Uniti Group (UNIT) were downgraded to Sell from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/18
07/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Veoneer (VNE) initiated with a Buy at Mizuho and a Neutral at Citi. 2. Huntsman (HUN) initiated with an Outperform at RBC Capital. 3. Autoliv (ALV) reinstated with a Sell at Societe Generale. 4. Chemours (CC) initiated with an Outperform at RBC Capital. 5. VF Corp. (VFC) initiated with an Outperform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
VNE Veoneer
$50.81

-1.81 (-3.44%)

07/18/18
SBSH
07/18/18
INITIATION
Target $51
SBSH
Neutral
Veoneer initiated with a Neutral at Citi
Citi analyst Itay Michaeli started Veoneer with a Neutral rating and $51 price target. The analyst also opened up a 90 day "upside catalyst watch" for the shares. The analyst believes Veoneer "still hasn't proven itself as a technology leader in higher-end level-2+ features." The analyst, however, is "fundamentally constructive" on the company's near-term news flow potential with regards to new advanced driver assistance system awards.
07/18/18
MZHO
07/18/18
INITIATION
Target $60
MZHO
Buy
Mizuho starts 'key enabler' Veoneer with Buy rating, $60 target
Mizuho analyst Vijay Rakesh last night initiated coverage of Veoneer with a Buy rating and $60 price target. The company is a "key enabler in the secular shift" in automotive from advanced driver assistance to highly automated and autonomous driving, Rakesh told investors in a research note. Veoneer is expected to grow to $4B in revenue by 2022 with active safety growing annually at 23%, the analyst points out.
07/17/18
MZHO
07/17/18
INITIATION
Target $60
MZHO
Buy
Veoneer initiated with a Buy at Mizuho
Mizuho initiated Veoneer with a Buy and $60 price target.
DLPH Delphi Technologies
$44.78

-0.355 (-0.79%)

07/09/18
07/09/18
UPGRADE
Target $55

Overweight
Morgan Stanley sees opportunity in trade worries, ups Delphi to Overweight
As previously reported, Morgan Stanley analyst Armintas Sinkevicius upgraded Delphi Technologies to Overweight from Equal Weight, noting that the stock is down 30% from its 52-week high amid concerns regarding the U.S. trade dispute with China, Mexico and the EU. He also believes investors are concerned about Europe's Worldwide Harmonised Light Vehicle Test Procedure, which must be in place for all vehicles by September of this year. However, he believes concerns over both of these create an opportunity for investors. Sinkevicius maintains a $55 price target on Delphi shares.
06/14/18
OPCO
06/14/18
INITIATION
OPCO
Perform
Delphi Technologies initiated with a Perform at Oppenheimer
Oppenheimer analyst Noah Kaye started Delphi Technologies with a Perform rating, stating that he views it as a leading vehicle propulsion solutions provider and that management's current long-term outlook may be conservative. However, the potential for upward revision of estimates may already be reflected in consensus, he believes.
06/15/18
06/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. PetMed Express (PETS) initiated with a Neutral at CL King. 2. Cloudera (CLDR) initiated with a Reduce at Nomura Instinet. 3. Sarepta (SRPT) initiated with a Buy at BTIG. 4. Delphi Technologies (DLPH) initiated with a Perform at Oppenheimer. 5. Enerplus (ERF) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
MSCO
07/09/18
UPGRADE
MSCO
Overweight
Delphi Technologies upgraded to Overweight from Equal Weight at Morgan Stanley
APTV Aptiv
$92.95

-2.02 (-2.13%)

04/04/18
BREN
04/04/18
UPGRADE
BREN
Buy
Aptiv upgraded to Buy from Hold at Berenberg
Berenberg analyst Fei Teng upgraded Aptiv to Buy.
06/22/18
RBCM
06/22/18
NO CHANGE
Target $115
RBCM
Outperform
Aptiv price target raised to $115 from $110 at RBC Capital
RBC Capital analyst Joseph Spak raised his price target on Aptiv to $115 and kept his Outperform rating, saying his latest meetings with the company's VP and Director of Investor Relations were "highly" encouraging regarding its business trajectory. Spak says the discussion revolved around the company's diversification strategy to reach up to 25% of revenues to be non-automotive by 2025, noting the adjacent CV market as well as opportunities in aero, military, oil & gas, and diversified industrials. The analyst also raised his FY18 EPS target to $5.43 from $5.38.
06/05/18
WELS
06/05/18
NO CHANGE
Target $118
WELS
Outperform
Aptiv price target raised to $118 from $105 at Wells Fargo
Wells Fargo analyst David Lim raised his price target for Aptiv to $118 from $105 as he believes it is one of the best plays in the auto supplier realm. The analyst thinks it will not be easy for new competition to match Aptiv's technology. Further, the strong book of business points to potential EPS and revenue upside relative to the 2022 outlook, he contends. Lim reiterates an Outperform rating on the shares.
05/03/18
DBAB
05/03/18
UPGRADE
Target $110
DBAB
Buy
Aptiv upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Rod Lache upgraded Aptiv to Buy and raised his price target for the shares to $110 from $108. The analyst revisited his growth assumptions following yesterday's Q1 results. He believes Aptiv posted strong organic growth in Q1.

TODAY'S FREE FLY STORIES

12:05
09/20/18
09/20
12:05
09/20/18
12:05
General news
Libor has been moving higher »

Libor has been moving…

SKY

Skyline

$28.20

-2.405 (-7.86%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Skyline falls -7.9% »

Skyline is down -7.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

SSW

Seaspan

$8.05

-1.105 (-12.08%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Seaspan falls -12.2% »

Seaspan is down -12.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THO

Thor Industries

$92.17

-13.55 (-12.82%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Thor Industries falls -12.8% »

Thor Industries is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTL

Mechel

$3.29

0.335 (11.34%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Mechel rises 12.8% »

Mechel is up 12.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEW

Puxin Limited

$8.51

0.94 (12.42%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Puxin Limited rises 13.2% »

Puxin Limited is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNST

Monster Beverage

$60.26

0.95 (1.60%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Options
Monster Beverage option volume is 3X daily average and calls lead puts 10:1 »

Monster Beverage option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COE

China Online Education

$7.00

(0.00%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
China Online Education rises 15.9% »

China Online Education is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPOA

Social Capital

$9.88

-0.05 (-0.50%)

11:55
09/20/18
09/20
11:55
09/20/18
11:55
Hot Stocks
Social Capital's Palihapitiya says no longer accepting new outside capital »

In a Medium post entitled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
09/20/18
09/20
11:55
09/20/18
11:55
Conference/Events
William Blair business services analyst holds group luncheon »

Business Services Analyst…

11:55
09/20/18
09/20
11:55
09/20/18
11:55
Conference/Events
Stephens specialty finance analyst to hold a group luncheon »

Specialty Finance Analyst…

MGTI

MGT Capital Investments

$0.00

(0.00%)

11:52
09/20/18
09/20
11:52
09/20/18
11:52
Hot Stocks
MGT Capital Investments announces partnership with MMH Blockchain »

MGT Capital Investments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTA

Axalta Coating

$30.16

0.23 (0.77%)

11:50
09/20/18
09/20
11:50
09/20/18
11:50
Options
Axalta Coating Systems attracts bullish option spreads »

Axalta Coating Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAF

GrafTech

$20.10

1.015 (5.32%)

11:49
09/20/18
09/20
11:49
09/20/18
11:49
Recommendations
GrafTech analyst commentary  »

GrafTech selloff brings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

11:45
09/20/18
09/20
11:45
09/20/18
11:45
Options
Tandem Diabetes call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 27

    Nov

BYSI

BeyondSpring

$25.55

(0.00%)

11:44
09/20/18
09/20
11:44
09/20/18
11:44
Conference/Events
BeyondSpring management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

11:43
09/20/18
09/20
11:43
09/20/18
11:43
Conference/Events
RBC Capital healthcare tech analyst to hold analyst/industry conference call »

Healthcare Technology…

EB

Eventbrite

$0.00

(0.00%)

11:36
09/20/18
09/20
11:36
09/20/18
11:36
Syndicate
Breaking Syndicate news story on Eventbrite »

Eventbrite opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

DNR

Denbury Resources

$5.49

-0.095 (-1.70%)

11:35
09/20/18
09/20
11:35
09/20/18
11:35
Options
Denbury Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ELAN

Elanco

$0.00

(0.00%)

, LLY

Eli Lilly

$105.79

0.03 (0.03%)

11:28
09/20/18
09/20
11:28
09/20/18
11:28
Syndicate
Elanco opens at $32.25, IPO priced at $24.00 per share »

Elanco Animal Health…

ELAN

Elanco

$0.00

(0.00%)

LLY

Eli Lilly

$105.79

0.03 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

  • 01

    Oct

  • 04

    Oct

  • 20

    Sep

ELAN

Elanco

$0.00

(0.00%)

, LLY

Eli Lilly

$105.64

-0.12 (-0.11%)

11:25
09/20/18
09/20
11:25
09/20/18
11:25
Syndicate
Breaking Syndicate news story on Elanco, Eli Lilly »

Elanco indicated to open…

ELAN

Elanco

$0.00

(0.00%)

LLY

Eli Lilly

$105.64

-0.12 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

  • 01

    Oct

  • 04

    Oct

  • 20

    Sep

RF

Regions Financial

$19.41

0.25 (1.30%)

11:25
09/20/18
09/20
11:25
09/20/18
11:25
Options
Regions Financial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHTR

Charter

$331.64

1.88 (0.57%)

11:25
09/20/18
09/20
11:25
09/20/18
11:25
Conference/Events
FBN Securities media analyst to hold a group luncheon »

Media Analyst Routh holds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

ACHV

Achieve Life Sciences

$2.53

0.05 (2.02%)

11:25
09/20/18
09/20
11:25
09/20/18
11:25
Conference/Events
Achieve Life Sciences to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

11:25
09/20/18
09/20
11:25
09/20/18
11:25
Conference/Events
William Blair insurance analyst to hold a luncheon meeting »

Insurance Analyst Klauber…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.